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Abstract
Introduction: Niacin reduces vascular oxidative stress and down regulates
inducible nitric oxide synthase, an enzyme mediating proatherosclerotic effects in
part by increasing oxidative stress. Here, we evaluate whether Niacin reverses the
redox sensitive migratory arrest of macrophages in response to oxidised(ox) LDL
uptake.
Material and Methods: Migration of RAW264.7 cells, a murine macrophage cell
line and bone marrow derived macrophages from wildtype and iNOS knockout mice
was quantified using a modified Boyden chamber. Unstimulated cells or cells
preincubated with oxLDL or non-oxidised (n)LDL were treated with Nicotinic acid or
Nicotinamide. Nitric oxide, peroxynitrite and ROS production were assessed using
electron paramagnetic resonance (ESR). Additionally, flow cytometry analysis of
apoptosis, fokal adhesion kinase (FAK), phalloidin, CD36, F4/80 macrophage
marker and iNOS gene expression (PCR) were assessed.
Results: Migration of Nicotinic acid, Nicotinamide treated cells or unstimulated
cells did not differ (P.0.05). oxLDL treatment significantly reduced migration vs.
unstimulated cells (p,0.05). In contrast, migratory arrest in response to oxLDL
treatment was reversed by co-incubation with Nicotinic acid and Nicotinamide. The
oxLDL-induced peroxynitrite formation in RAW264.7 cells was abolished by Niacin
and glutathion (GSH) oxidation was significantly reduced. However, nitric oxide
(NO)- and reactive oxygen species (ROS) production induced by oxLDL were not
affected by Niacin treatment of RAW264.7 cells. In addition, Nicotinic acid and
Nicotinamide reduced actin polymerization, a marker for migratory arrest.
Discussion: Our data shows that oxLDL induced inhibition of macrophage
migration in vitro can be reversed by Niacin. Furthermore, Niacin reduces
peroxynitite formation and improves antioxidant GSH.
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Introduction
Niacin referring to Nicotinic acid and Nicotinamide has been used for almost
sixty years to treat dyslipidemia in order to reduce/prevent atherosclerosis. As
such Niacin markedly reduces plasma triglycerides, LDL-cholesterol, lipoprotein
a, fibrinogen, plasminogen activator inhibitor-1 and increases HDL-C [1]. In the
ARBITER 2 study Niacin in combination with statins slowed the progression of
CAD and reduced cardiovascular events, an observation also made in several
smaller studies [2, 3]. While most of the antiatherosclerotic effects are believed to
result from its lipid modifying activity some evidence suggests that Nicotinic acid
also reduces cardiovascular mortality independent from its lipid modifying
properties [4]. In this respect, Niacin reduces plaque development independent of
lipid lowering or HDL elevation in LDL receptor knockout mice [5]. In contrast,
Niacin reduces atherosclerosis in ApoE*3Leiden.CETP mice, a model closely
resembling human lipoprotein metabolism, mainly by reducing non HDL
cholesterol [6]. Despite these positive results larger clinical trials like HPS2-
THRIVE failed to show an additional risk reduction when Niacin/Laropiprant was
given to patients already reaching target cholesterol levels with statin treatment
[7]. Furthermore, AIM-HIGH was stopped prematurely because of a lack of
benefit of Niacin [8]. Several reasons warrant further elucidation of these
seemingly discrepant results, i.e. patients who reach target lipid levels have a
relevant residual risk for adverse cardiovascular outcomes. Additionally, high risk
patients intolerant to statins verify the need for alternative lipid lowering
medications.
Nicotinamide, the metabolite of Nicotinic acid, also influences oxidative stress
and has broad activities on many cell types, including regulation of cell adhesion,
polarity, migration, proliferation and differentiation [9, 10]. Interestingly, Niacin
also downregulated the expression of the inducible nitric oxide synthase in
adipocytes, an enzyme expressed in atherosclerotic lesions which is capable of
simultaneous generation of high concentrations of nitric oxide and superoxide.
iNOS is not found in healthy vessels, however, in the microenvironment of
inflammatory atherosclerotic lesions iNOS is expressed by macrophage/foam cells
and vascular smooth muscle cells [11, 12]. The expression of inducible nitric oxide
synthase (iNOS) in early and advanced atherosclerotic human and murine
plaques may modulate cellular and molecular mechanisms that initiate and
propagate atherosclerosis [13, 14]. Our previous research has shown that iNOS
increases plaque development and lipid peroxides in atherosclerotic apoE
knockout mice [15]. Furthermore, our past results have shown that iNOS
simultaneously increases NO and O2- production and nitrosative/oxidative stress
in the atherosclerotic plaques [16]. Changes in oxidative stress are associated with
changes in macrophage/foam cell mobility [17] and recently published data from
our laboratory suggests that nitrosative stress and subsequent lipid-peroxide
formation are involved in trapping macrophage foam cells in the plaque [18].
Therefore, we here evaluate the role of Nicotinic acid and Nicotinamide in
reversing the migratory arrest of macrophages in response to oxLDL uptake of
Niacin Reverses Migratory Arrest
PLOS ONE | DOI:10.1371/journal.pone.0114643 December 18, 2014 2 / 18
RAW264.7 cells, a well charaterised model of macrophage foam cells as well as in
primary bonemarrow cells of wild type and iNOS ko mice.
Materials and Methods
Reagents and antibodies
Nicotinic acid (N0761), Nicotinamide (N0636), NAC (A9165) and MCP-1, were
obtained from Sigma. nLDL was obtained from Applichem (A6961). Dil-oxLDL
was obtained from KALEN (770232-9). oxLDL was generated by incubating nLDL
with 10 mM CuSO4 in PBS for 18 hours at 37 C̊ [19]. For veryfication of LDL
oxidation we performed an MDA-TBA HPLC assay and documented a significant
increase in malondialdehyde (data not shown) signal [20]. The FITC-Annexin
apoptosis kit was obtained from Becton Dickinson (556570). Antibodies used
were directed towards following antigens: Nitrotyrosine (9691, Cell Signaling),
FITC-phalloidin (P5282, Sigma), FAK (sc-932, Santa Cruz), iNOS (sc-650, Santa
Cruz), b-Actin (sc-130656, Santa Cruz), APC-F4/80 (17-4801-82, eBioscience),
FITC-CD36 (ab92560, abcam) and p-FAK (ab76244, abcam).
Animals
Mice were backcrossed for 10 generations to the C57BL/6J genetic background.
iNOS knockout (ko) mice were obtained from The Jackson Laboratories. All
procedures performed were approved by the ethics committee of the medical
faculty of the Ludwig-Maximilians-Universität München and the administration
of Oberbayern (Approval No. 55.2-1-54-2532.3-67-12).
Preparation of bone marrow cell derived macrophages (BMC)s
For BMC isolation, C57BL/6J and iNOS ko mice (8 weeks old, male) were
euthanised by cervical dislocation and the femur and tibial bones were removed.
BMCs were flushed with Dulbecco’s Modified Eagle Medium (DMEM, 31966-
021, Gibco) from the medullary cavities using a 25-G needle. Then, cells were
cultured in DMEM medium supplemented with 10% fetal bovine serum, 1%
penicillin/streptomycin in a 75 cm2 culture flasks (3290, Corning) and incubated
at 37 C̊, 5% CO2. Cells from every two mice were cultured in one 75 cm
2 culture
flasks.
After 24 hours, 20 ng/ml mouse macrophage colony stimulating factor (M-CSF
Mouse, CS-C2038, Cellsystems) was added into medium.
Cell Culture
The murine macrophage cell line, RAW264.7 (CLS), was cultured and propagated
in RPMI 1640 medium (31870-074, Gibco) supplemented with 10% fetal bovine
serum (10500-064, Gibco), 2 mM L-glutamine (Biochrom) and 1% penicillin/
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streptomycin (Biochrom) in a 75 cm2 culture flasks at 37 C̊ in humidified
atmosphere containing 5% CO2 and air.
In vitro migration assay (modified Boyden chamber migration
assay)
Cell migration was assessed in a modified Boyden chamber using trans-well
inserts with a 5 mm porous membrane (3421, Corning). Cells were first pre-
treated with nLDL (100 mg/ml), oxLDL (100 mg/ml), Nicotinic acid (1 mM,
3 mM) or Nicotinamide (1 mM, 3 mM) at 37 C̊ in 5% CO2 for 24 hours. Cells
were then washed twice with PBS. Fifty thousand cells per group were added to
100 ml medium and introduced into the upper compartment of the trans-well.
Into the lower compartment of the Boyden chamber 600 ml medium containing
MCP-1 in a concentration of 10 ng/ml was added. The chambers were incubated
at 37 C̊ in 5% CO2 for 18 hours. During this time cells in the upper compartment
were allowed to migrate to the lower side of the membrane. Membrane were
harvested and cells on the lower side of the membrane fixed with methanol for
8 minutes and then stained with 1 drop of DAPI (Vector). At last, the lower side
of the membrane was photographed using a fluorescence microscope with a 610
objective. The number of the cells per picture were counted by Image Pro-Plus
v.4.5 (The Proven Solution).
Flow cytometry assays
To quantify apoptosis following oxLDL and Niacin treatment cells were washed
twice with PBS. Then 105 cells were suspend with 16binding buffer incubated
with FITC–annexin V and propidium Iodine (PI) at room temperature for
15 minutes in the dark, and then analyzed.
To measure the uptake of oxLDL, RAW264.7 cells were incubated with Dil-
oxLDL (20 mg/ml) or Dil-oxLDL plus Nicotinic acid or Nicotinamide at 37 C̊ in
5% CO2 for 2 hours. After that cells were washed twice by PBS and fluorescence
intensity was quantified.
To measure polymerised actin (F-actin), RAW264.7 cells were pre-incubated
with nLDL, oxLDL or oxLDL plus Nicotinic acid or Nicotinamide at 37 C̊ in 5%
CO2 for 24 hours. Following incubation, cells were washed twice with PBS, and
105 cells were suspended in FACS buffer (PBS with 1% BSA) and fixed in 4%
paraformaldehyde for 8 minutes. Cells were washed twice, treated with 0.1%
Triton and stained with FITC-conjugated phalloidin at room temperature for
60 minutes in the dark and fluorescence intensity was quantified.
To measure phosphorylation of focal adhesion kinase (p-FAK), RAW264.7 cells
were pre-incubated with nLDL, oxLDL or oxLDL plus Nicotinic acid or
Nicotinamide at 37 C̊ in 5% CO2 for 24 hours. Following incubation, cells were
washed twice with PBS, and 105 cells were suspended in FACS buffer (PBS with
1% BSA), fixed with 4% paraformaldehyde for 8 minutes, treated with 0.1%
Triton and then incubated with anti-p-FAK antibody at room temperature for
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40 minutes in the dark. Then cells were incubated with Alexa Fluor 488
conjugated secondary antibody (ab150077, abcam) at room temperature for
40 minutes in the dark, washed twice and fluorescence intensity was quantified.
For F4/80 and CD36 staining of BMCs 105 cells were suspended in FACS buffer,
followed by incubation with APC–F4/80 antibody at room temperature for
60 minutes in the dark. Subsequently, cells were washed twice with PBS and
fluorescence intensity was quantified.
All flow cytometry was performed using a BD FACScan (Calibur). Data were
analyzed by Flowjo 7.6.1.
Real time PCR
Total RNA was extracted from cells using TriFast reagent (30-2010, peqGOLD).
cDNA was synthesized from 1 mg of total RNA using iScript cDNA synthesis kit
(170-8890, Bio-Rad) following the manufacturer’s instructions. Gene expression
was analyzed by quantitative RT-PCR using the EVA Green PCR Master MIX
(172-5201, Bio-Rad) with the Mx3000P detection system and relative quantifi-
cation software (Stratagene). The expression levels of each gene were determined
using the comparative Ct method and normalized to b-actin, as internal control.
The primers are listed in Table 1.
Western blot
RAW264.7 cells were lysed using RIPA buffer (89900, Thermo). Lysates were
separated by SDS-PAGE, transferred to PVDF membranes and probed with
antibodies for b-Actin (1:500 diluted), 3-nitrotyrosine (1:200 diluted), iNOS (1:200
diluted) and p-FAK (1:1000 diluted), followed by chemiluminescence detection.
Band intensities were quantified using Image J. Immunoprecipitations were
performed following the Immunoprecipitation Kit’s instructions (10006D, novex).
HPLC
Cells were washed twice with PBS and treated on ice with tri-n-butylphosphine in
dimethylformamide for 30 min at 4 C̊. After that cells were scraped and sonicated and
GSH and GSSG were measured and calculated respectively by HPLC as described [21].
Measurement of NO Production by Electron Spin Resonance
(ESR)
NO production of RAW264.7 cells was measured using iron-diethyldithiocarba-
mate (Fe(DETC)2) as a spin trap and ESR detection. Briefly, cells were washed
twice by PBS and suspended in 4 C̊ chilled Krebs-Hepes Buffer (KHB). 10 ml
FeSO4 and 10 ml DETC solutions were bubbled with N2 for 20 min, and each
250 ml were added to each dish (total amount 1 ml). NO produced by cells was
captured by Fe-(DETC)2 for 1 hour in 37 C̊ KHB. Cells were scraped and 100 ml
of the cell suspension was frozen in liquid N2 and subject to ESR analysis.
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Following ESR measurement the protein concentration of each sample was
quantified with a protein assay reagent (Bio-Rad) and used to normalize ESR
signal intensity. ESR measurements were done using a bench top e-scan ESR
spectroscope. The instrumental settings were listed in Table 2.
Measurement of reactive oxygen species (ROS) and peroxynitrite
by ESR
The generation of ROS by RAW264.7 cells was measured by ESR detection (e-scan
ESR spectrometer). A stock solution of spin probe (1-hydroxy-3-methoxycarbo-
nyl-2,2,5,5-tetramethylpyrrolidine, CMH) (10 mM, 2.3 mg for 1 ml KHB) in
buffer containing 25 mM Defferoxamine (DF) and 5 mM DETC was prepared. 106
cells seeded in 6-wells were washed twice by PBS and then suspended in KHB
containing 25 mM DF and 5 mM DETC at 4 C̊. 100 mL of cell suspension and
2.5 mL of spin probe solution were mixed. ROS production was assessed by
incubating cells with CMH for 30 min at 37 C̊. The reaction was stopped on ice.
Uric acid (Sigma) was used as a scavenger for peroxynitrite [22]. Peroxynitrite
formation of RAW264.7 cells was calculated as the difference of ROS production
between each group before and following uric acid treatment. Following ESR
measurement the protein concentration of each sample was quantified with a
protein assay reagent (Bio-Rad) and used to normalize ESR signal intensity.
The instrumental settings were listed in Table 2.
Statistics
Statistical analysis was performed using ANOVA. A P-value of less than 0.05 was
considered significant. Data are expressed as mean¡SD. The analyses were
formed using SPSS Statistics 17.0.
Results
Nicotinic acid and Nicotinamide reverse oxLDL mediated
migratory arrest of RAW264.7 cells
The migration of cells treated with Nicotinic acid or Nicotinamide only,
compared to the unstimulated group did not significantly differ. (P.0.05)
(Fig. 1A, 1B) oxLDL treatment significantly reduced macrophage migration
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compared to unstimulated cells (74.4¡11.2 versus 179.1¡81.5, p,0.05), while
the migratory arrest in response to oxLDL treatment was reversed by coincubation
with Nicotinic acid at the concentration of 1 mM (74.4¡11.2 versus 196.2¡65.6,
p,0.05). Interestingly, the migratory arrest in response to oxLDL treatment was
also reversed by coincubation with Nicotinamide with both concentration of
1 mM (74.4¡11.2 versus 166.4¡53.2 p,0.05) and 3 mM (74.4¡11.2 versus
233.8¡53.0, p,0.05).(Fig. 1C, 1D). Additionally, the ROS scavanger tempol and
NAC were also able to reverse the migratory arrest induced by oxLDL(Fig. 1D).
Nicotinic acid and Nicotinamide did not influence Apoptosis of
RAW264.7 cells
To exclude the possibility that changes in migration were caused by differences in
cell viability between the different treatment groups, we analyzed Annexin V and
propidium lodine staining of the RAW264.7 cells by flow cytometry. All
measurements were performed five times for each group. The percentage of dead
cells (PI and Annexin V double positive cells) of each group were baseline
(10¡6.63), nLDL (14.7¡2.99), oxLDL(13.3¡2.54), oxLDL+Nictinic acid
100 mM (10.4¡4.64), oxLDL+Nictinic acid 1 mM(11.1¡4.32),
oxLDL+Nicotinamide 1 mM (11.9¡3.41), oxLDL+Nicotinamide
3 mM(10.3¡2.81). There were no significant differences between the percentage
of live cells, apoptotic cells and dead cells between groups.
Nicotinic acid and Nicotinamide did not change oxLDL uptake and
expression of F4/80 by RAW264.7 cells
To investigate whether the uptake of oxLDL by RAW264.7 cells changes following
Nicotinic acid or Nicotinamide treatment we quantified fluorochrome labeled
Dil-oxLDL uptake of cells by FACS. While in general no differences in LDL uptake
were noted between groups, the highest dose of Nicotinamide (3 mM)
significantly reduced oxLDL uptake of RAW264.7 cells. (Fig. 2A) Additionally, the
expression of F4/80, a macrophage maker and CD36, a scavenger receptor of
Table 2. Electron Spin Resonance settings for NO, ROS and peroxynitrite Measurement.
Measurement of NO Measurement of reactive oxygen species (ROS) and peroxynitrite
Centre field 3308 G 3388 G
Sweep width 80 G 132 G
Microwave frequency 9.495 GHz 9.497 GHz
Microwave power 50 mW 1.25 mW
Modulation Amplitude 4.6 G 1.63 G
Modulation frequency 86 kHz 86 kHz
Time constant 81.92 ms 40.96 ms
Time constant 20.48 ms 10.24 ms
Number of scans 30 50
doi:10.1371/journal.pone.0114643.t002
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RAW264.7 cells were measured by flow cytometry. The expression of F4/80 did
not differ between groups. (Fig. 2B) However, the fluorescence intensity of CD36
of oxLDL treated cells was significantly stonger compared to unstimulated cells,
but was significantly reduced when cells were treated with Nicotinic acid 100 mM,
Nicotinamide 1 mM and 3 mM (Fig. 2C).
Fig. 1. Migration assay of RAW264.7 cells. A. Migrated RAW264.7 cells on the lower side of the membrane
were stained with DAPI and counted under a fluorescence microscope using a 610 objective. Representitive
pictures of each treatment group. B. Migrated cells of each group. The migration of cells between each group
was not significantly different. (P.0.05, n55). C. Migrated RAW264.7 cells on the lower side of the membrane
were stained with DAPI and counted under a fluorescence microscope using a 610 objective. Representitive
pictures of each treatment group. D. Migrated cells of each group. Significance was determined by ANOVA.
(*, p,0.05, D, p,0.05 compared with oxLDL group, n55).
doi:10.1371/journal.pone.0114643.g001
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Fig. 2. Flow cytometry of Dil-oxLDL, and F4/80. A. Cells were preincubated with Dil-oxLDL, then Nican in a
concentration of 100 mM or 1 mM, or Nicotinamide in a concentration of 1 mM or 3 mM were added. The
fluorescence intensity of Dil-oxLDL treated cells was significantly reduced when cell were treated with
Nicotinamide at 3 mM. (*, P,0.05, n55). B. The fluorescence intensity of F4/80 of each group was not
significantly different (P.0.05, n55). C. Fuorescence intensity of CD36 in each group. (*, P,0.05, n55).
doi:10.1371/journal.pone.0114643.g002
Niacin Reverses Migratory Arrest
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oxLDL induced iNOS Expression of RAW264.7 cells was reduced
by Niacin
We used realtime PCR and western blot to see whether the iNOS expression
differed between treated groups. (Fig. 3A and 3B) iNOS expression was increased
following oxLDL treatment and significantly reduced by co-incubated with
Niacin.
Niacin leads to a reduction in peroxynitrite generation induced by
oxLDL
With the co-incubation with Nicotinic acid and Nicotinamide, the oxLDL-
induced peroxynitrite formation in RAW264.7 cells measured by ESR was
abolished. Additionally, western blot analysis of 3-Nitrotyrosine, considered a
footprint of peroxynitrite formation revealed similar results. However, NO- and
ROS production induced by oxLDL were not affected by Nicotinic acid and
Nicotinamide treatment of RAW264.7 cells, but decreased ROS production by
oxLDL was reversed by 1400W, an iNOS inhibitor (Fig. 3C, 3D, 3E, 3F and 3G).
oxLDL induced Glutathione disulfide (GSSG)/Glutathione (GSH)
was reduced by Niacin
Antioxidant enzymes, such as glutathione peroxidases and peroxiredoxins,
generate glutathione disulfide during the reduction of peroxides such as H2O2 and
ROOH. Glutathione disulfide (GSSG)/Glutathione (GSH) was measured by
HPLC. Incubation of cells with oxLDL increased GSSG, and this increase was
reversed by co-incubation with Nicotinic acid and Nicotinamide (Fig. 3H).
Nicotinic acid and Nicotinamide reverse oxLDL mediated
migratory arrest of bone marrow cells
Here, we isolated bone marrow derived macrophages of iNOS knockout and wild
type mice to test differences in cell migration in a model of chronic iNOS
deficiency. To confirm that bone marrow derived cells were indeed macrophages,
we stained the freshly isolated cells for F4/80 and CD36 and analyzed them by flow
cytometry. (Fig. 4A) Under baseline conditions iNOS knockout macrophages
migrated to the same extent as wild type macrophages. In contrast, in the presence
of oxLDL, wild type macrophage migration was significantly inhibited, while
iNOS knockout macrophage migration was not inhibited. Moreover, Nicotinic
acid and Nicotinamide reversed migratory arrest in wild type macrophages,
however, there was no additional gain in migration in the iNOS knockout groups
(Fig. 4B, 4C).
Niacin Reverses Migratory Arrest
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oxLDL induced focal adhesion kinase and actin polymerization
were reduced by Niacin
As the inhibition of cell migration may be associated with enhancement of focal
adhesion kinase (FAK) phosphorylation and actin polymerization we measured
these markers. Real time PCR analysis revealed no difference in the expression of
focal adhesion kinase (t-FAK) between groups (Fig. 5A).
But indeed, phosphorylation of the focal adhesion kinase (p-FAK) showed a
significant increase of p-FAK in oxLDL treated RAW264.7 cells, an effect which
Fig. 3. Measurement of iNOS, p-FAK, 3-Nitrotyrosine expression, production of NO, ROS, superoxide, peroxynitrite and GSSG/GSH in RAW264.7
cells. A. iNOS expression of RAW264.7 cells of each group was tested by ‘‘real time’’ PCR using comparative CT method. (*, P,0.05, n53). B.
Representative western blot of iNOS expression of RAW264.7 cells of each group. (*, P,0.05, n53). C. The intracellular NO production was measured by
ESR. (*, P,0.05, n55). D. Intracellular ROS and superoxide was measured by ESR. (*, P,0.05, n55). E. Intracellular ROS was measured by ESR.
(*, P,0.05, n55). F. Representative western blot of 3-Nitrotyrosine. Band intensities were quantified by ImageJ and normalized to b-actin. (*, P,0.05, n53).
G. Extracellular peroxynitrite was measured by ESR. (*, P,0.05, n56). H. GSSG/GSH of RAW264.7 cells measured by HPLC.(*, P,0.05, n54).
doi:10.1371/journal.pone.0114643.g003
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was completely abolished by Nicotinic acid, Nicotinamide or NAC treatment by
FACS analysis. (Fig. 5B) Moreover, additional western blot analysis for p-FAK/t-
FAK showed simlar results (Fig. 5C).
FACS analysis showed that the amount of polymerized actin did not differ
between baseline and nLDL treatment. However, oxLDL treatment increased
Fig. 4. Migration assay of bone marrow derived macrophages. A. Bone marrow derived macrophages were stained with fluorochrome labeled anti-F4/
80 and anti-CD36 antibodies. Fluorescence intensity was analysed by flow cytometry. B. Migrated RAW264.7 cells on the lower side of the membrane were
stained with DAPI and counted under a fluorescence microscope using a 610 objective. Representitive pictures of each treatment group. C. Migration of
oxLDL treated cells was significantly reduced compared to unstimulated cells. Migration of oxLDL treated cells was significantly different compared to
Nicotinic acid 1 mM, Nicotinamide 1 mM and 3 mM. (*, P,0.05, n55).
doi:10.1371/journal.pone.0114643.g004
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phalloidin staining, an effect which was abrogated by Nicotinic acid and
Nicotinamide (Fig. 5D, 5E).
Discussion
In contrast to a large body of evidence regarding the mechanisms by which statins
protect against cardiovascular disease, the cardioprotective mechanisms of Niacin
are still not completely understood.
The water soluble vitamin Niacin (Vitamin B3) was originally described as an
antiatherosclerotic drug due to its ability to reduce plasma non HDL lipids and
increase HDL cholesterol [2]. Additional atheroprotective effects which are
independent of lipid lowering involve modulation of oxidative stress [4] as well as
broad activities on many cell types, including regulation of cell adhesion, polarity,
migration, proliferation and differentiation [9, 10]. Although the recent large
outcome trials AIM-HIGH and HPS2-THRIVE failed to reveal additional
Fig. 5. Expression of t-FAK and phalloidin in RAW264.7 cells. A. t-FAK expression of RAW264.7 cells of each group was tested by ‘‘real time’’ PCR using
comparative CT method. (n55). B. The expression of p-FAK in RAW264.7 cells of each group was subjected to analysis by flow cytometry. (*, p,0.05,
n55). C. Expression of p-FAK and t-FAK was measured by western blot. (*, P,0.05, n53). D. RAW264.7 cells were stained with FITC-phalloidin and
subjected to analysis by flow cytometry.(n55). E. RAW264.7 cells of each group were stained with FITC-phalloidin and DAPI and then photographed under
a fluorescence microscope using a 663 objective.
doi:10.1371/journal.pone.0114643.g005
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beneficial effects of Niacin on top of statin treatment in patients with on target
LDL choleterol plasma concentrations [23, 24]. other studies have shown that
nicotinic acid may have beneficial effects in acute and chronic vascular disease
independently of its effects on plasma lipids [5, 25]. Moreover, Niacin reduces
atherosclerosis in hyperlipidemic mice and experimental evidence suggest that the
antiatherogenic effects involve modulation of lipid profiles as well as lipid
independent mechanisms. Along these lines data indicates that Niacin inhibits
vascular inflammation by decreasing endothelial ROS production, subsequent
LDL oxidation and inflammatory cytokine release [4]. New strategies to reduce
inflammation and increase reverse cholesterol transport by modulating immune
cell signaling involved in the progression of atherosclerosis have been proposed as
innovative approaches to prevent and treat atherosclerosis. Interestingly, Niacin
was found to reduce iNOS expression in adipocytes [26]. Data from our lab
revealed that iNOS inhibition in macrophage foam cells reduces nitrosative stress
and lipid peroxide formation, which in turn restores migration in oxLDL fed cells
[18].
Moreover, our previous research revealed reduced atherosclerotic plaque
development upon reduction of nitrosative stress in atherosclerotic apoE
knockout mice [13, 15]. Furthermore, our past results show that iNOS increases
nitrosative stress in atherosclerotic plaques [16].
Here we demonstrate that Niacin reverses the migratiory arrest of macrophage
foam cells by oxLDL uptake. Our data demonstrates that Niacin reduces oxLDL
induced iNOS expression and nitrosative stress. Furthermore, we found that
Niacin reduces actin polymerization and the phosphorylation of focal adhesion
kinase (p-FAK). The latter finding is of significance since actin-based motility,
driven by the assembly of actin filaments determines direct movement of cells.
The cell migration process consists of actin polymerization driven lamellipodia
extension, disruption of existing- and formation of new focal contacts [27].
Mechanistically, this inhibition was associated with enhancement of focal
adhesion kinase (FAK) phosphorylation and actin polymerization [17, 28]. Since
the signaling pathway required for actin polymerization includes activation of
FAK [29], it has been suggested that the sustained activation of FAK [30] and its
hyperphosphorylation is associated with the inhibition of cell migration [31].
In the current study we performed a detailed analysis of oxidative stress using
ESR spectroscopy to measure reactive oxygen species (ROS), NO and
peroxynitrite production by iNOS since oxidative stress may directly lead to
vascular injury. In atherosclerotic lesions oxidative stress is increased compared to
healthy vascular tissue, suggesting that oxidative stress is one important mediator
or direct factor causing the trapping of macrophages in the intima [32]. In order
to antagonize oxidative stress cells have developed potent antioxidative strategies.
As such glutathione (GSH) is an important antioxidant in plants, animals, fungi
and some bacteria and archaea, preventing damage to important cellular
components caused by reactive oxygen species such as free radicals and peroxides
[33]. Antioxidant enzymes, such as glutathione peroxidases and peroxiredoxins,
generate glutathione disulfide (GSSG) during the reduction of peroxides like
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hydrogen peroxide (H2O2) and organic hydroperoxides (ROOH) [34]. Our
results indicate that oxidation of intracellular GSH is reduced following Niacin
treatment. Interestingly, total NO and ROS levels did not change following Niacin
treatment.
Our study reveales that Niacin reversed the decrease of ROS- and specifically
superoxide production caused by oxLDL uptake and reduced the oxLDL mediated
increase of peroxynitrite formation in RAW264.7 cells as measured by ESR and
western blot. oxLDL may have caused a decrease of superoxide concentration
because superoxide reacted with NO to form peroxynitrite. The formation of
peroxynitrite is a diffusion controlled reaction with a rate constant of
6,76109 mol-l s-1 between O2
2 and NO, which is three times faster than
enzymatic degradation of O2
2 [35]. Our results are in line with this proposed
biochemistry. Treatment of oxLDL fed RAW264.7 cells with the iNOS inhibitor
W1400 leads to an increase of ROS production. Moreover, treatment of oxLDL
fed RAW264.7 cells with SOD revealed that the O2
2 signal vanished completely
and previous publications indicate that high concentrations of O2
2 react with NO
to form peroxinitrite in a way completely consuming O2
2 [36].
We found a difference in iNOS expression, however, changes in expression
levels did not change enzyme activity to make a significant difference to NO
production. A possible explanation is that aside from its transcriptional
regulation, multiple post-translational modifications of iNOS have been identified
that allow complex regulation of the catalytic activity of these enzymes [37–42].
The observation that Niacin inhibited the formation of peroxynitrite may
render an explanation for our finding that net superoxide production of
RAW264.7 cells was not reduced.
Recently published data from our laboratory showed that increased
peroxynitrite formation leads to increased production of lipid peroxides [18],
which are strong inducers of protein tyrosine phosphatases (PTPs) by their
oxidation [43]. In this way, oxidative inactivation of PTP may result in sustained
phosphorylation of FAK and increased actin polymerization, causing migratory
arrest.. In agreement with this concept scavenging of ROS increased migration in
oxLDL treated cells in our experiments. Interestingly, Nicotinamide, a metabolite
of Niacin shows the same or an even stronger effect on reversing oxLDL mediated
inhibition of cell migration.
In conclusion, our results reveal that oxLDL induced inhibition of macrophage
migration may be reversed by Niacin, rendering a novel explanation for Niacin’s
atheroprotective effects on cardiovascular disease independent of its effects on
plasma lipids. Furthermore, Niacin reduced peroxynitrite formation and GSH
oxidation.
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